Skip to main content
OpenTrials

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

1,810 public trials 143 recruiting studies
Refine in advanced search Browse all conditions

Dyslipidemias trial results

Completed

Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.

NCT05763875

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Parkway Medical Center Birmingham, Alabama, United States
  • SEC Clinical Research Dothan, Alabama, United States
  • Hillcrest Medical Research DeLand, Florida, United States
  • ClinCloud Maitland, Florida, United States
View all 42 locations
View Trial Details
Completed

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

NCT02089217

Conditions
Arterial Occlusive Diseases, Brain Diseases, Cardiovascular Diseases, +12 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Huntsville Hospital/ Heart Center Research Alabama Huntsville, Alabama, United States
  • Banner University Medical Center Phoenix, Arizona, United States
  • St. Joseph's Hospital and Medical Center/Barrow Neurological Institute Phoenix, Arizona, United States
View all 167 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy

NCT04669041

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Investigational Site Number :1560033 Baotou, China
  • Investigational Site Number :1560001 Beijing, China
  • Investigational Site Number :1560068 Beijing, China
  • Investigational Site Number :1560021 Beijing, China
View all 40 locations
View Trial Details
Completed

A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

NCT05952856

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Alliance for Multispecialty Research, LLC ( Site 0093) Daphne, Alabama, United States
  • G&L Research ( Site 0043) Foley, Alabama, United States
  • Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0084) Phoenix, Arizona, United States
  • National Heart Institute-Research ( Site 0087) Beverly Hills, California, United States
View all 168 locations
View Trial Details

Related conditions